Mei J. Dong
Harbin, 150086, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Cardio-Oncology in Cold Climates: Epidemiological Features, Bidirectional Interaction Mechanisms, and Integrated Management Strategies.
Journal: Cardiovascular toxicology
Published: June 01, 2026
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 06, 2026
Cost-effectiveness analysis of larotrectinib vs standard of care for treatment of metastatic NTRK fusion colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 12, 2025
Plasma Vitamin C Levels in Distinguishing Benign from Malignant Breast Tumors and Clinical Correlates in Chinese Patients: A Cross-Sectional Study.
Journal: Breast cancer (Dove Medical Press)
Published: November 06, 2025
Personalizing Liposomal Paclitaxel in Platinum-Based Combination Therapy for Gynecologic Cancers: Defining a Therapeutic Window Based on Tc>0.05 and CYP2C8 Metabolic Capacity.
Journal: European journal of drug metabolism and pharmacokinetics
Published: September 06, 2025
Cost-effectiveness analysis of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer after 16 weeks of first-line therapy.
Journal: Annals of medicine
Published: July 05, 2025
Cost-effectiveness analysis of dostarlimab plus chemotherapy versus pembrolizumab plus chemotherapy as first-line treatment of metastatic non-squamous non-small cell lung cancer.
Journal: Journal of chemotherapy (Florence, Italy)
Published: June 28, 2025
Cost-effectiveness analysis of adagrasib with or without cetuximab in the treatment of colorectal cancer patients with mutated KRAS G12C.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: June 16, 2025
Cost-effectiveness analysis of sotorasib plus panitumumab in the treatment of refractory colorectal cancer with mutated KRAS G12C in the USA.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: June 16, 2025
Cost-effectiveness analysis of FOLFOXIRI plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment of metastatic colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 21, 2025
The Relationship Between IL-6 and IL-10 Expression Levels and the Prognosis in B-Cell Non-Hodgkin Lymphoma Patients Treated with R-CHOP.
Journal: Journal of inflammation research
Published: April 03, 2025
Last Updated: 09/26/2026